Ultimate magazine theme for WordPress.

OpGen provides business updates and financial results for

ROCKVILLE, Maryland, October 28, 2021 (GLOBE NEWSWIRE) – OpGen, Inc. (NASDAQ: OPGN) (“OpGen” or “the Company”) announced today that the company will provide a business update and report on its third quarter 2021 financial results after US financial markets close on Thursday, November 11, 2021. OpGen’s management team will host a live conference call and audio webcast at 4:30 pm Eastern time to discuss the company’s financial results and an update to give business activities.

Conference call details
US dial-in number: 1-877-705-6003
International access number: 1-201-493-6725
Webcast: http://public.viavid.com/index.php?id=146838
Conference ID: 13723808
Playback details
US dial-in number: 1-844-512-2921
International access number: 1-412-317-6671
Repeat PIN: 13723808

After the conference call is over, a replay will be available through November 25, 2021. The live webcast of the conference call is also available through the Investors section of the company’s website at www.opgen.com. A replay of the webcast will be available after the conference call closes and will be archived on the company’s website under Finance and Records.

About OpGen, Inc.

OpGen, Inc. (Rockville, MD, USA) is a precision medicine company leveraging the power of molecular diagnostics and bioinformatics to fight infectious diseases. Together with our subsidiaries Curetis GmbH and Ares Genetics GmbH, we develop and commercialize molecular microbiology solutions that help doctors obtain faster and actionable information about life-threatening infections in order to improve treatment outcomes and reduce the spread of infections caused by multi-drug resistant microorganisms or MDROs . OpGen’s product portfolio includes Unyvero, Acuitas AMR Gene Panel and Acuitas® Lighthouse, as well as the ARES technology platform including ARESdb, which uses NGS technology and AI-powered bioinformatics solutions to predict antibiotic responses.

More information is available at www.opgen.com.

OpGen:
Oliver Schacht
President and CEO
[email protected]

OpGen press contact:
Matthew Bretzius
FischTank Marketing and PR
[email protected]

OpGen investor contact:
Max Colbert
Edison group
[email protected]

Comments are closed.

%d bloggers like this: